Incidence and prevalence of non tuberculous mycobacteria [NTM] in adult CF population: A large adult CF centre experience Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013
New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC) Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Prospective study of nontuberculous mycobacteria (NTM) isolates in children with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 209s Year: 2002
Non-tuberculous mycobacteria (NTM) in bronchiectasis - a difficult management problem Source: Eur Respir J 2003; 22: Suppl. 45, 515s Year: 2003
Nontuberculous mycobacteria infection in patients with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 615s Year: 2004
Macrolides in cystic fibrosis (CF); clinical experience Source: Eur Respir J 2004; 24: Suppl. 48, 615s Year: 2004
ABPA syndrome (ABPAs) in CF: FEV1 decline, infectious exacerbations and BMI before and after the year of diagnosis (index year), a case control study Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Cases series on nontuberculous mycobacterial (NTM) lung disease and silicosis in Brazil Source: International Congress 2017 – Case reports and series Year: 2017
Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment? Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Non-tuberculous mycobacteria management in adult patients with Cystic Fibrosis: a retrospective study Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019
p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics Source: Eur Respir J 2006; 28: 1204-1210 Year: 2006
Nontuberculous mycobacterial disease in CF Source: ERS course 2015 Year: 2015
Tropical Australia is a potential reservoir of non-tuberculous mycobacteria in cystic fibrosis Source: Eur Respir J, 49 (5) 1700046; 10.1183/13993003.00046-2017 Year: 2017
Frequency of mycobacteriosis among the patients with positive cultures of nontuberculous mycobacteria (NTM) – 5 year study Source: Eur Respir J 2004; 24: Suppl. 48, 190s Year: 2004
Diagnostic and therapeutic difficulties in pulmonary aspergillosis (PA) in paediatric cystic fibrosis (CF) patients Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006
Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020
A possible association between breast cancer, bronchiectasis and nontuberculous mycobacterial (NTM) lung disease Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014